Current Signal Transduction Therapy


Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK


Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:13   Issue: 2
Pp: 81-81
Tao Jiang
DOI: 10.2174/157436241302180919120200

Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction free to download

Volume:13   Issue: 2
Pp: 82-82
Sisir Nandi
DOI: 10.2174/157436241302180919120338

Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads

Volume:13   Issue: 2
Pp: 83-104
Sisir Nandi*, Mohd Salman, Ankita Sharma and Mohit Kumar
DOI: 10.2174/1574888X13666180301124935

Integrin Antagonists: A Special Emphasis on Structural Requirements of N-benzoyl-L-biphenylalanines as α4β7 and α4β1 Antagonists

Volume:13   Issue: 2
Pp: 105-118
Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen and Tarun Jha*
DOI: 10.2174/1574888X13666180301123106

Application of Chemoinformatic Tools for the Design of Novel Molecules as anti-Parkinsonian Agents

Volume:13   Issue: 2
Pp: 119-128
Ashis Nandy* and Indrani Adhikari*
DOI: 10.2174/1574362413666180221114441

Therapeutic Molecules for Fumigating Inflammatory Tumor Environment

Volume:13   Issue: 2
Pp: 129-152
Adhikesavan Harikrishnan and Vijaykumar Veena*
DOI: 10.2174/1574362413666180402145336

Chimeric Antigen Receptors; Their Current and Futuristic Scope

Volume:13   Issue: 2
Pp: 153-158
Preeti Sharma*, Pradeep Kumar and Rachna Sharma
DOI: 10.2174/1574362413666180517085528

Comparison of Surface Electromyogram Signal for Prosthetic Applications

Volume:13   Issue: 2
Pp: 168-172
Karan Veer* and Renu Vig
DOI: 10.2174/1574362413666180202163305

Acknowledgements to Reviewers free to download

Volume:13   Issue: 2
Pp: 173-173

DOI: 10.2174/157436241302180919144000